4th Annual Conference

Transcription

1 4th Annual Conference Draft Agenda The Palazzo Hotel, Las Vegas Follow us on Pre-Conference Workshop, October 3rd, :00-5:30 pm MSL Workshop for new MSLs Location: Conference Room Elizabeth Kupferer, Director Medical Science Valeant Pharma Allyson Nelson, Field MSL Team Lead Bayer Healthcare Overview of MSL role Types of MSL roles based on company type, objectives MSL background education Regulatory 101 Scientific Acumen Types Review of the literature Journal Club Territory Management KOL engagement Geographical management Travel tips Welcome Reception, October 3rd, :00-9:00 pm Welcome Reception Location: The Palazzo Hotel, Las Vegas

2 Day One, October 4th, :00 Welcome/Opening Remarks Samuel Dyer, CEO and Chairman of the Board MSL Society 9:05 Real World Evidence for Adding Value to KOL Relationships Strategies for strengthening KOL relationships Case studies to demonstrate what kind of interventions can improve KOL engagement Michael Milane, Vice President, Medical Affairs Biofrontera 9:35 Developing KOL Relationships, and Using the Resources from These Relationships Using the resources generated from KOL relationships and interactions Prioritizing responsibilities to support stakeholders and execute projects Fostering and nurturing KOL relationships Jihad Rizkallah, Director, Medical Science Liaisons Sunovion Pharmaceuticals 10:05 Bringing Strategy to Life Through MSL Excellence Discuss how Sanofi-Genzyme redesigned how their MSL team operates to align with changes in strategy. Learn how standards, training, systems, and KPIs work together as a system to drive MSL excellence. Discover three important lessons that you can take back to your team for building MSL excellence. Scott Thompson, Managing Partner - Acceleration Point Scott Lucas, Regional Director, MSLs - Sanofi-Genzyme David Voight, Managing Partner - Acceleration Point 10:35 Networking Break 11:15 It is time for globally recognized MSL guidelines Exact presentation information coming soon Jennifer Williams, Former Director of Medical Science Liaison Services and Education 11:45 Establishing MSL Excellence Centers and Operational Models The importance of setting up support infrastructures for MSLs Operational models for training, on boarding and developing a unified CRM for MSLs Promoting MSLs across the organization Investing in the MSL team, and developing governance and progress KPIs Iris Depaz, Senior Director, Global Medical Science Liaisons Sanofi Pasteur 12:15 Lunch Break

3 1:15 Presentation Reserved For Veeva Systems Robert Groebel, Vice President, Medical Strategy Veeva Systems 1:45 Supporting New MSLs Through MSL Mentoring Programs The role of MSL mentors Developing effective MSL mentoring programs Transitioning from an MSL to an MSL mentor Supporting new MSLs through mentorship Christine Vaupel, Senior Medical Science Liaison - Genoptix, a Novartis Company Jinah Lee, Senior Medical Science Liaison - GlaxoSmithKline 2:15 Creating MSL Excellence Center for Global Governance Approach to MSL Effectiveness and Roadmap Vision to Ensure Global Footprint In Field Team Effectiveness Blueprint Importance of Insights Launching an MSL Community Ralph Rewers, Head of US MSLs AbbVie 2:45 Networking Break 3:30 The Changing Role of the MSL The changing healthcare environment and the key role for MSLs MSL relationship effectiveness with KOLs MSLs from company representative to trusted partner Short-term service delivery issues and long-term success models for engagement Internal and external scrutiny on the role and value of the MSL New skills sets for MSLs in a highly regulated environment Paul Meade, President Thought Leader Select Melody Davis, Associate Director, External Medical Affairs Teva Pharmaceuticals 4:00 Using Technology to Collect Field Data and Generate Insights The importance of gathering field insights and opinions to transform in to value The creation of a technology platform as a solution for the collection of field data insights The operationalization of captured insights to demonstrate value to stakeholders Ryan McClellan, Associate Director, Analytics and Technology Mike Abbadessa, Senior Director, Medical Affairs Takeda Pharmaceuticals

4 4:30 How to Build and Foster Innovation Within the RML Department Building infrastructure and fostering creative minds within the MSL department Identifying the technical experts Developing innovative approaches Identifying better technology for remote interactions Promoting value to upper management & senior executives Dan Anderson, Director, Scientific Affairs Amgen 5:00 Closing Remarks and End of Day One Samuel Dyer, CEO and Chairman of the Board MSL Society 7:00 Evening Reception: TBD Day Two, October 5th, 2016 Candidate/Student Stream MSL Stream MSL Leader Stream 9:00 11:00 New MSL Success Stories Tiama Chaar Medical Science Liaison Sanofi-Genzyme/TMAC Josh Yoder Medical Science Liaison Sanofi-Pasteur Perspective from NEW MSL(s) How to break into your first role Strategies utilized for interview success Delivering to internal and external stakeholders Developing the multifaceted skills for success 9:00-11:00 Enrich KOL Relationships with Emotional Intelligence Melody Davis Associate Director External Medical Affairs Teva Pharmaceuticals Improve Communication Skills Understand what means Learn techniques to understand, use, and appreciate the role of when engaging with KOLs Understand the different emotions and how to manage them How to work with and validate emotions with KOLs 9:00 11:00 Proven Active Listening Techniques to Enhance KOL Engagement Linda Traylor Sr. Director Medical Affairs Biodesix Identify ways to become a better listener Use body language to reflect a positive listening attitude Create a listening mindset using framing, positive intent, and focus Understand the KOL communication process Effective ways to ask questions, probe for information, and using paraphrasing techniques Build relationships to create an authentic communication experience Identify common listening problems and solutions.

5 11:00-11:45 Networking Break 11:45-12:30 Live Fellow Poster Session All attendees will break from workshops to attend this session. 12:30 1:30 Lunch Candidate/Student Stream MSL Stream MSL Leader Stream 1:30 3:30 What is a Hiring Manager Looking for? Speaker TBC What hiring managers are looking for from a candidate What is an MSL and what do they do Why most applications get rejected and what you can do about it What makes an MSL successful What salary to expect as a new MSL How to address your lack of MSL experience 1:30 3:30 Proven Active Listening Techniques to Enhance KOL Engagement Linda Traylor Sr. Director Medical Affairs Biodesix Identify ways to become a better listener Use body language to reflect a positive listening attitude Create a listening mindset using framing, positive intent, and focus Understand the KOL communication process Effective ways to ask questions, probe for information, and using paraphrasing techniques Build relationships to create an authentic communication experience Identify common listening problems and solutions 1:30 3:30 Leveraging Emotional Intelligence as a Manager Melody Davis Associate Director External Medical Affairs Teva Pharmaceuticals Improve Communication Skills Understand what means Learn techniques to understand, use, and appreciate the role of when engaging with KOLs Understand the different emotions and how to manage them How to work with and validate emotions with KOLs Communication Skills for Managers Difficult Conversations with KOLs Building long-term KOL relationships and adding value

6 3:30 4:15 Networking Break 4:15 Panel Session: Best Practices for MSL Training Interactive panel session exploring MSL training Develop a best in-house MSL team Create onboarding initiatives for MSLs Emily Scalise, Director, Medical Science Liaisons Fresenius Medical Care Gaurav Sharma, Associate Director, Medical Affairs Actelion Pharma Rashmi Morani, Medical Science Liaison Fresenius Medical Care 4.45 MSL Coaching Optimizing Capabilities and Driving Success More specific information will arrive soon Sian Davis, Head of Medical Capabilities AstraZeneca 5.15 Closing Remarks and End of Conference Samuel Dyer, CEO and Chairman of the Board MSL Society